Stephen Ranere represents technology and life sciences companies, from startup through IPO and beyond. Steve also advises venture capital and private equity firms involved in the technology, life sciences, and other growth industries.

Steve leverages extensive experience to help clients in a broad range of sectors — including fintech, climate tech, digital health, and AI-enabled drug discovery — navigate:

  • Early-stage formation and strategy
  • Venture capital and growth equity financings
  • Mergers and acquisitions 
  • Public offerings of securities
  • Public company representation
  • Corporate governance matters

He marshals the resources across Latham’s robust global platform to craft solutions for clients at any stage of corporate development.

A recognized leader within the firm, Steve serves on the Digital Health Task Force and was previously on the firm’s Associates Committee.

He maintains an active pro bono practice, including participating in legal workshops for small-business owners in underserved communities.

Stephen’s representative clients include:

Technology and Consumer

  • Blackbird Labs
  • ButterflyMX
  • Divert
  • Evolv Technology
  • MadHive
  • MaryRuth Organics
  • Merlin Labs
  • ModernFi
  • OfferFit
  • Snyk
  • Trust Machines
  • Watts Water Technologies

Life Sciences and Digital Health

  • Affini-T Therapeutics
  • BlueWhale Bio 
  • Guaranteed Health
  • Hemanext
  • Overjet
  • Owkin 
  • PathAI
  • Theradaptive 

Venture Capital and Private Equity

  • 3L Capital 
  • A2 Ventures
  • Asymmetric Capital Partners
  • General Catalyst
  • Valor Equity Partners

Bar Qualification

  • Massachusetts

Education

  • JD, Suffolk University Law School, 2008
    summa cum laude
  • BA, Harvard University, 2000